Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson innovative Medicine identifiable assets ($M) ($M)
Form 10-K Segment Note
Latest, Q3 2026
78,944
Period ended Sep 30, 2026
Change on a year earlier
+6.1%
74,422 in Q3 2025
History
16 quarters
Since Q4 2016
Sources
14
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Innovative Medicine identifiable assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 78,944 | +6.1% | Form 10-Q (filed 2026-10-21) ↗ |
| Q2 2026 | Jun 28, 2026 | 78,856 | +4.5% | Form 10-Q (filed 2026-07-23) ↗ |
| Q1 2026 | Mar 29, 2026 | 78,118 | +33.0% | Form 10-Q (filed 2026-04-22) ↗ |
| Q4 2025 | Dec 28, 2025 | 78,057 | +36.8% | Form 10-Q (filed 2026-10-21) ↗ |
| Q3 2025 | Sep 28, 2025 | 74,422 | – | Form 10-Q (filed 2025-10-22) ↗ |
| Q2 2025 | Jun 29, 2025 | 75,487 | – | Form 10-Q (filed 2025-07-24) ↗ |
| Q1 2025 | Mar 30, 2025 | 58,727 | – | Form 10-Q (filed 2025-04-23) ↗ |
| Q4 2024 | Dec 29, 2024 | 57,070 | -2.2% | Form 10-K (filed 2026-02-11) ↗ |
| Q4 2023 | Dec 31, 2023 | 58,324 | -0.2% | Form 10-K (filed 2025-02-13) ↗ |
| Q4 2022 | Jan 1, 2023 | 58,436 | -9.2% | Form 10-K (filed 2024-02-16) ↗ |
| Q4 2021 | Jan 2, 2022 | 64,376 | -2.7% | Form 10-K (filed 2023-02-16) ↗ |
| Q4 2020 | Jan 3, 2021 | 66,158 | +17.5% | Form 10-K (filed 2022-02-17) ↗ |
| Q4 2019 | Dec 29, 2019 | 56,292 | -0.6% | Form 10-K (filed 2021-02-22) ↗ |
| Q4 2018 | Dec 30, 2018 | 56,636 | -4.7% | Form 10-K (filed 2019-02-20) ↗ |
| Q4 2017 | Dec 31, 2017 | 59,450 | +116.4% | Form 10-K (filed 2019-02-20) ↗ |
| Q4 2016 | Jan 1, 2017 | 27,477 | – | Form 10-K (filed 2018-02-21) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Innovative Medicine identifiable assets ($M) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/seg_assets_im
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.